Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Clinical Trials, Platforms & Cohorts

Learn more about all of the Clinical Trials, Platforms & Cohorts at the Wal-yan respiratory centre.

News & Events

National Asthma Week: 10 things you need to know about asthma

Asthma affects about half a million Australian children and is one of the most common reasons why kids need to see a doctor or go to emergency.

The facts

On average, a person can expect to take more than 700 million breaths in their lifetime.

Asthma

Respiratory disease is a global issue and international networks are critical to informing best-practice approaches to the clinical care and management of childhood respiratory health.

News & Events

Study sheds new light on the ‘autism epidemic’ mystery

Researchers have shown that the so called 'autism epidemic' is due to an increase in the diagnosis of children with less severe behavioural symptoms.

News & Events

The Kids researcher awarded support funding

A The Kids Research Institute Australia researcher has been awarded $10,000 in State Government research support funding.

News & Events

Free vaccines for pregnant mums see monumental rise in protection for WA babies

New collaborative research involving almost 600,000 pregnant mothers has demonstrated a dramatic increase in uptake of the whooping cough (pertussis) vaccine after identifying just 22 per cent of WA women had the maternal vaccination between 2012 – 2017.

First-hand fight inspires generous gift

A close call with meningococcal disease ignited a passion in Iain Buchan to do whatever he can to keep WA children safe from life-threatening infectious diseases.

News & Events

Skin infections flying under the radar

The Kids Research Institute Australia researchers have confirmed that skin infections in many Aboriginal children across northern Western Australia are going unrecognised.

News & Events

RSV vaccine for pregnant women provides protection for babies: study

A world-first study has found a new vaccine against potentially deadly respiratory syncytial virus (RSV) is safe and effective for use in pregnant women, to help protect their babies.